Laima Tihomirova - Concepedia

Author

Laima Tihomirova

Latvian Biomedical Research and Study Centre

Also Known As

Alex Teulé, De La Hoya, Miguel, Edith Olah, Javier Benitez, Kathryn L. Terry, Kenneth Offit, L Tihomirova, L. P. Tihomirova, L. Tihomirova, Laima Tihomirova

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Latvian Biomedical Research and Study Centre Centre de Recherche en Cancérologie de Lyon Pomeranian Medical University Cancer Genetics (United States)University of Utah

About

Laima Tihomirova is an author at Latvian Biomedical Research and Study Centre specializing in genetics, medicine, and genetic variation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	86
2	Natural Sciences	2	2	147
3	Molecular Genetics	2	2	31
4	Biology	1	1	127
5	Pathology	1	1	55

Laima Tihomirova

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i> / <i>2</i> (CIMBA) Nasim Mavaddat, Daniel Barrowdale, Irene L. Andrulis, Cancer Epidemiology Biomarkers & Prevention	2012	649
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer Timothy R. Rebbeck, Nandita Mitra, Fei Wan, JAMA	2015	484
Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Implications for Risk Prediction Antonis C. Antoniou, Jonathan Beesley, Lesley McGuffog, Cancer Research	2010	184
On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations Nancy Hamel, Bing Feng, Lenka Foretová, European Journal of Human Genetics BiologyNatural SciencesGeneticsEvolutionary BiologyBrca1 C.5266dupc	2010	127
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer Fergus J. Couch, Karoline Kuchenbaecker, Kyriaki Michailidou, Nature Communications	2016	120
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers Antonis C. Antoniou, Karoline Kuchenbaecker, Penny Soucy, Breast Cancer Research	2012	95
Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia Béla Csókay, Laima Tihomirova, Aivars Stengrēvics, Human Mutation Recurrent MutationBreast OncologySomatic VariantStrong Founder EffectsMedicine	1999	55
Analysis of point mutations of the BRCA1 gene by hybridization with hydrogel microarrays O. E. Fedorova, Olga Siņicka, Laima Tihomirova, Molecular Biology	2006	20
Haplotype analysis and ancient origin of the BRCA1 c.4035delA Baltic founder mutation Ramūnas Janavičius, Vilius Rudaitis, Bing Feng, European Journal of Medical Genetics Allelic VariantGenetic DisorderComparative GenomicsGeneticsEvolutionary Biology	2012	20
The 4154delA mutation carriers in the BRCA1 gene share a common ancestry Silvija Ozolina, Olga Siņicka, Eriks Jankevics, Familial Cancer Genetic DisorderGeneticsCommon AncestryGenetic MechanismMolecular Genetics	2008	11

Page 1